<DOC>
	<DOCNO>NCT02625662</DOCNO>
	<brief_summary>This study focus symptom , natural history clinical impact facioscapulohumeral muscular dystrophy ( FSHD ) child . Symptoms classical FSHD start adulthood . However , small subgroup FSHD patient early , childhood onset . This early onset associate faster progression symptom like hear loss epilepsy . The symptom , natural history clinical impact FSHD child largely unknown . The result study vital adequate symptomatic management trial-readiness .</brief_summary>
	<brief_title>Facioscapulohumeral Dystrophy Children</brief_title>
	<detailed_description>FSHD hereditary muscle disease slowly progressive muscle weakness . In child heterogenic disease range severely affected infant mildly affect adolescent . Symptoms include muscle weakness , pain , fatigue , epilepsy , hear loss , vision loss , mental retardation spinal deformity . The prevalence symptom adequate follow-up symptom unknown . Moreover clinical impact social function child FSHD expose . Therefore study focus total spectrum FSHD child . In addition , extensive genetic screening conduct , search ( epi ) genetic disease modifier severity predictor .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Facioscapulohumeral</mesh_term>
	<criteria>age 017 year symptoms facial , scapulohumeral peroneal weakness genetically proven FSHD1 FSHD2 live Netherlands informed consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>muscular dystrophy</keyword>
	<keyword>natural history</keyword>
	<keyword>genetic profilling</keyword>
</DOC>